Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-019199

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Apr 30, 2015
Accepted (ET)
May 12, 2015 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 30, 2015A389$51.2635A110,089D
Common StockF2Apr 30, 2015G389$0.00D109,700D
Common StockApr 30, 2015G389$0.00A24,324IShares held by Baffi Family Trust
Common StockMay 8, 2015G1,912$0.00D107,788D
Common StockF3May 8, 2015G1,912$0.00A26,236IShares held by Baffi Family Trust
Common StockMay 8, 2015F2,088$121.66A105,700D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses